EU could approve AstraZeneca vaccine by end-January: EMA

Credit: Pixabay/CC0 Public Domain

The EU's medicines regulator said Friday that a decision to authorise the use of the AstraZeneca-Oxford coronavirus vaccine could be made by the end of the month.

The announcement came with the bloc under pressure to speed up the rollout of vaccines against the virus, which has claimed the lives of more than 600,000 people across the continent.

The Amsterdam-based European Medicines Agency said it was expecting AstraZeneca to submit a conditional marketing application for the vaccine next week.

"Possible conclusion—end of Jan, depending on and evaluation progress," it said in a tweet.

The agency approved the use of the Pfizer-BioNTech in December and the Moderna jab on Monday.

Approval of the shot developed by AstraZeneca and Oxford University "will of course depend on the data we receive and the evaluation progress", EMA chief Emer Cooke told a videoconference.

"Once we actually receive the application, we will make a public announcement on this," Cooke added.

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

© 2021 AFP

Citation: EU could approve AstraZeneca vaccine by end-January: EMA (2021, January 8) retrieved 15 April 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments